Skip to content

Effects of single dose dexmedetomidine in combination with propofol in patients undergoing endoscopic digestive ultrasonography for diagnosis and treatment

Effects of single dose dexmedetomidine in combination with propofol in patients undergoing endoscopic digestive ultrasonography for diagnosis and treatment

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900024572
Enrollment
Unknown
Registered
2019-07-18
Start date
2019-09-01
Completion date
Unknown
Last updated
2019-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

diseases which need digestive endoscopic ultrasonography for diagnosis and treatment

Interventions

Group DP:Sedation with dexmedetomidine and propofol

Sponsors

The First Affiliated Hospital, College of Medicine, Zhejiang University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Inhospital patients undergoing endoscopic digestive ultrasonography for diagnosis and treatment; 2. ASA I-III; 3. Aged 18-80 years; 4. Willing to sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. Severe cardiopulmonary dysfunction; 2. Severe psycological and psychiatric disorders; 3. Pregnant and breastfeeding patients; 4. Severe liver dysfunction (Child Pugh class C); 5. contraindications for anesthetic drugs; 6. Dependence on alcohol and drugs; 7. Hemoglobin < 6g/L.

Design outcomes

Primary

MeasureTime frame
Recovering time;

Secondary

MeasureTime frame
Dose of propofol and sufentanil;Occurrence of hypoxia;Occurrence of hypotension;occurrence of brandycardia;Satisfaction of pateints and endoscopic physician;occurrence of posoperative nausea and vomiting;Severity of postoperative pain;Occurrence of body movement when endoscopy pass through throat;Use of vasoactive drugs and their dose;occurrence of aspiration;

Countries

China

Contacts

Public ContactFang Xiangming

The First Affiliated Hospital, College of Medicine, Zhejiang University

Xiangming_fang@163.com+86 13857161019

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026